Medscape
TOPLINE: Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs), including liraglutide or semaglutide, for 12 months enabled patients to lose nearly all the weight they had regained after bariatric surgery. METHODOLOGY: Researchers conducted a single-centre retrospective study to examine the efficacy and safety of 12 months of treatment with GLP-1 RAs in patients who …
Read More
Combat Post–Bariatric Surgery Weight Regain With GLP-1 RAs
Qiana Grumbles
11:22
TOPLINE: Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs), including liraglutide or semaglutide, for 12 months enabled patients to lose nearly all the weight they had regained after bariatric surgery. METHODOLOGY: Researchers conducted a single-centre retrospective study to examine the efficacy and safety of 12 months of treatment with GLP-1 RAs in patients who
